AcuCort AB
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-3,846.94%Profit Margin
Unprofitable62,078.97Revenue
-2.39MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Specializing in pharmaceutical innovation, AcuCort AB (publ) focuses on the development and commercialization of glucocorticoid dexamethasone film products, particularly for acute allergic conditions. Among its offerings is Zeqmelit, a medication with diverse therapeutic uses. Zeqmelit addresses severe and acute allergic reactions, pediatric croup, chemotherapy-induced nausea and vomiting, and also serves as a treatment for COVID-19 patients who require supplemental oxygen. The company, established in 2006, is headquartered in Lund, Sweden.
Show More
CEO
Jonas Jonmark
Employees
5
Country
Sweden
ISIN
SE0009695927
Listings
0 Comments
Share your thoughts
FAQs
What is AcuCort AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange AcuCort AB stocks are traded under the ticker NV5.STU.
What is AcuCort AB revenue for the last year?▼
AcuCort AB revenue for the last year amounts to 62,078.97 EUR.
What is AcuCort AB net income for the last year?▼
NV5.STU net income for the last year is -2.39M EUR.
How many employees does AcuCort AB have?▼
As of November 3, 2026, the company has 5 employees.
In which sector is AcuCort AB located?▼
AcuCort AB operates in the Health & Wellness sector.
When did AcuCort AB complete a stock split?▼
AcuCort AB has not had any recent stock splits.
Where is AcuCort AB headquartered?▼
AcuCort AB is headquartered in Lund, Sweden.